12 research outputs found
Myocardial infarction: Summary of the timi trials
- Author
- Publication venue
- 'Wiley'
- Publication date
- Field of study
No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy
- Author
- Publication venue
- 'Wiley'
- Publication date
- Field of study
Low-Molecular-Weight Heparin Therapy in Acute Coronary Syndromes
- Author
- Antman E.M.
- Antman E.M.
- Antman E.M.
- Antman E.M.
- Cairns J.A.
- Cohen M.
- Cohen M.
- FRISC Study Group.
- Gurfinkel E.P.
- Haft J.I.
- Hirsh J.
- Klein W.
- Lewis H.D.
- Mark D.B.
- Oler A.
- PRISM-PLUS Study Investigators.
- The PURSUIT Trial Investigators.
- The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators.
- Theroux P.
- Theroux P.
- Weitz J.I.
- Yeghiazarians Y.
- Publication venue
- 'SAGE Publications'
- Publication date
- Field of study
Modelling the occurrence and severity of enoxaparin-induced bleeding and bruising events
- Author
- Antman
- Antman
- Aroney
- Barras
- Beal
- Beal
- Berges
- Berkowitz
- Brophy
- Bruno
- Buller
- Cockroft
- Cohen
- Eriksson
- Ettte
- Feng
- Granger
- Green
- Green
- Green
- Green
- Han
- Hulot
- Hulot
- Janmahasatian
- Janmahasatian
- Kane-Gill
- Merli
- Montalescot
- Moscucci
- Mould
- Parke
- Quinlan
- Samama
- Sanchez-Pena
- Snow
- The SYNERGY Trial Investigators
- Thrombolysis in Myocardial Infarction (TIMI) 11A Investigators
- Zhang
- Publication venue
- Blackwell Science Inc
- Publication date
- Field of study
A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease
- Author
- Antman
- Bertrand
- Boden
- Cairns
- Cohen
- Cohen
- Eikelboom
- FRagmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
- FRagmin and Fast Revascularisation during Instability in Coronary artery disease (FRISC II) Investigators
- FRagmin during Instability in Coronary artery disease (FRISC) study group
- Granger
- Gurfinkel
- Hamm
- Hirsh
- Holdright
- Kaul
- Kereiakes
- Klein
- Lewis
- Lindahl
- Lindahl
- Merlini
- The FRAX.I.S. Study Group
- The RISC Group
- The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators
- Thrombin Inhibition in Myocardial Ischaemia (TRIM) Study Group
- Théroux
- Théroux
- Théroux
- Wallentin
- Wallentin
- Publication venue
- 'Wiley'
- Publication date
- Field of study
Newer antithrombin agents in acute coronary syndromes
- Author
- Ambrose
- Antman
- Antman
- Antman
- Antman
- Antman
- Antman
- Ardissino
- Bittl
- Cannon
- Cannon
- Cohen
- Collignon
- Danielsson
- Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
- Fuster
- Fuster
- Gold
- Gurfinkel
- Harker
- Hirsh
- Hirsh
- Klein
- Liu
- Maraganore
- Markwardt
- Neuhaus
- Oler
- Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators
- Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators
- Rosenberg
- Ryan
- Serruys
- Simes
- The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators
- The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators
- The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators
- The TIMI IIIB Investigators
- Weitz
- Weitz
- Weitz
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
Gender differences in the effects of cardiovascular drugs
- Author
- American College of Cardiology/American Heart Association Task Force on Practice Guidelines
- American Heart Association Statistics Committee and Stroke Statistics Subcommittee
- Antithrombotic Trialists' Collaboration
- APPROVE Investigators
- ARISTOTLE Committees and Investigators
- ASSENT-2 Investigators. Assessment of the Safety and Efficacy of a New Thrombolytic
- ATLAS ACS 2–TIMI 51 Investigators
- Authors/Task Force Members
- AVERROES Steering Committee and Investigators
- BEAUTIFUL Investigators
- Beta-Blockers in Heart Failure Collaborative Group
- Canadian Acute Coronary Syndrome Registry I and II Investigators
- Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
- Carvedilol Prospective Randomized Cumulative Survival Study Group
- CHAMPION PHOENIX Investigators
- CHARM Investigators and Committees
- Cholesterol Treatment Trialists' (CTT) Collaboration
- Collaboration Antithrombotic Trialists
- CRUSADE Investigators
- ENGAGE AF-TIMI 48 Investigators
- Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
- ESPRIT Investigators
- ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events) and TIMI (Thrombolysis in Myocardial Infarction) 11B Investigators
- EUGenMed Cardiovascular Clinical Study Group
- European Atherosclerosis Society Consensus Panel
- Fibrinolytic Therapy Trialists' (FTT) Collaborative Group
- Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators
- For the ACE inhibitor myocardial infarction collaborative group
- For the Amlodipine Cardiovascular Community Trial Study Group
- For the GUSTO-I Investigators
- For the HOT Study Group
- For the SWORD Investigators
- Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
- Gruppo Italiano per lo Studio Della Streptochinasi nell'Infarto Miocardico (GISSI)
- Gusto V Investigators
- INITIATIVE Investigators
- Institute of Medicine (US) Committee on Women's Health Research Board on Population Health
- INTERHEART Study Investigators
- ISCOAT Study Group (Italian Study on Complications of Oral Anticoagulant Therapy)
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
- LIFE Study Group
- National Institutes of Health
- OASIS-6 Investigators
- OASIS-6 Trial Group
- Office of Extramural Research NIH
- OPTIMAAL Steering Committee of the OPTIMAAL Study Group
- PARADIGM-HF Committees Investigators
- PARADIGM-HF Investigators and Committees
- PLATO Investigators
- PLATO study group
- RE-LY Steering Committee and Investigators
- REMIT Investigators
- REPLACE-2 Investigators
- REPLACE-2 Investigators
- ROCKET AF Investigators
- SCAAR Study Group
- SHIFT Investigators
- SYNERGY Trial Investigators
- The GUSTO Investigators
- The Heart Outcomes Prevention Evaluation Study Investigators
- The MERIT-HF Study Group
- The SOLVD Investigattors
- TIMI 11A Investigators
- TRITON-TIMI 38 Investigators
- US General Accounting Office (GAO)
- VALIANT Investigators
- Valsartan Heart Failure Trial Investigators
- Valsartan in Acute Myocardial Infarction Trial Investigators
- VALUE Trial Group
- Women's Health Initiative Investigators
- Working Group on Thrombosis of the Italian Society of Cardiology
- Writing Group for the Women's Health Initiative Investigators
- Publication venue
- 'Oxford University Press (OUP)'
- Publication date
- Field of study
Low-Molecular-Weight Heparins: Are they all the Same?
- Author
- Alban
- Andrassy
- Antman
- Bara
- Bendz
- Bick
- Carrie
- Cohen
- Davidoff
- Dolovich
- Eikelboom
- Ellison
- Eriksson
- Eriksson
- Fareed
- Fareed
- Fragmin and Fast Revascularisation during Instability in Coronary Artery Disease Investigators
- Fragmin during Instability in Coronary Artery Disease (FRISC) Study Group
- Freedman
- Geerts
- Gori
- Gould
- Group
- Gurfinkel
- Hirsh
- Hodl
- Hull
- Hyers
- Jeffrey S. Ginsberg
- Kaul
- Klein
- Koch
- Krotenberg
- Leizorovicz
- Lindahl
- Lopez
- McCart
- Mismetti
- Mismetti
- Montalescot
- Morris
- Oosta
- Palmer
- Planès
- Racine
- Richard H. White
- Schumock
- The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators
- Van Der Heijden
- Verheugt
- Weitz
- Wells
- Westrich
- Publication venue
- 'Wiley'
- Publication date
- Field of study
Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
- Author
- Abbate
- Ambrose
- Ambrose
- Antman
- Antman
- Antman
- Antman
- Antman
- Antman
- Ardissino
- Baird
- Bara
- Bara
- Barzu
- Bassand
- Bastani
- Bertrand
- Bhatt
- Blazing
- Boersma
- Boneu
- Cairns
- Cannon
- Casele
- Cella
- Choussat
- Cohen
- Cohen
- Cohen
- Cohen
- Collet
- Coulter
- Davies
- Davies
- DeWood
- Duplaga
- Eikelboom
- Eisenberg
- Eisenberg
- Elliott M. Antman
- Ernofsson
- Ferguson
- Fitzgerald
- Fox
- Frostfeldt
- Goodman
- Goodman
- Graham C. Wong
- Gram
- Hansen
- Hansen
- Hansen
- Harenberg
- James
- Karsch
- Kaul
- Kereiakes
- Kereiakes
- Kereiakes
- Kerins
- Klein
- Kontny
- Libby
- Lindahl
- Lindahl
- Martin
- Melandri
- Merlini
- Merlini
- Merlini
- Michalis
- Montalescot
- Morrow
- Mukherjee
- Rabah
- Robert P. Giugliano
- Ross
- Sandset
- Seitz
- Serra
- Simoons
- Smith Jr
- Tatu-Chitoiu
- The ASSENT 3 Investigators
- The FRAXIS Investigators
- The FRISC II Investigators
- The FRISC II Investigators
- The FRISC Study Group
- The SYNERGY Executive Committee
- The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators
- Wallentin
- Wallentin
- Weitz
- Weitz
- Xiao
- Young
- Zijlstra
- Publication venue
- 'American Medical Association (AMA)'
- Publication date
- Field of study
The appropriateness of enoxaparin use in Lebanese hospitals: a quality evaluation study
- Author
- A Bazinet
- A Turpie
- AT Taher
- B Boneu
- BA Duplaga
- C Kearon
- C Macie
- D Scholten
- DJ Quinlan
- DW Cockcroft
- E Tincani
- G Cheymol
- G Merli
- G Montalescot
- G Sanderink
- H Al-Sallami
- H Al-Sallami
- I Gouin-Thibalt
- I Mahe
- J Ferguson
- J Hirsh
- J Hirsh
- J Nieto
- JI Weitz
- K Spicer
- M Blazing
- M Cohen
- M Ellis
- M Rondina
- M Rothberg
- N Kucher
- P Chopard
- R Becker
- R Harrington
- R Masroujeh
- S Wilson
- Sanofi-Aventis US LLC
- The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators
- V Vats
- W Geerts
- W Lim
- World Health Organization
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study